Adel Kardosh
机构：Oregon Health & Science University · ORCID：0000-0002-6241-4896
发表论文 165 篇 · 总被引 2920 次 · h-index 23
代表论文
- Cyclic immunofluorescence platform using photocleavable linkers for direct antibody labeling enables cancer phenotyping (2026 · bioRxiv (Cold Spring Harbor Laboratory))
- Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial (2026 · Journal of Clinical Oncology)
- Figure 2 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
- Supplementary Figure S8 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
- Supplementary Data 3 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
- Supplementary Data 5 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)